IL-6 stimulates hepatic lipogenesis (54), and is associated with obesity (55), impaired insulin signaling (56, 57), and altered insulin sensitivity by activating key steps in the insulin signaling pathway (58). The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.